| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.1 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.1 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.1 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.1 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |